Tuesday , May 18 2021

Fibroid drug related to serious liver problems, Health Canada warns



A review of drug safety for treating Uterine fibroids in health in women during pregnancy found that it is possible that their use and the risk of rare but serious liver disease.

Fibroids are cancerous tumors that develop in the tissues of the uterus; Many women with fibroids do not have any symptoms, but sometimes they can cause menstrual bleeding and cramping.

The federal revision of fibrillation has received four international reports of liver injuries after liver transplants; He has worked with Allergan's manufacturer to update drug safety information, including new restrictive uses.

Fibral should not be used in current women, or had problems with liver problems, and it could not be regularly used for fibroid-removal surgery for non-surgical children.

Fibrals such as fatigue, yellow skin, urine darkness, or nausea and vomiting develop medication and should contact a doctor immediately.

Health Canada has said that doctors should not face fibroids in the liver's current or anterior liver problems, and should be advised for patients who need to continue their liver function before and after treatment.


Source link